DALLAS, Feb. 05, 2019 (GLOBE NEWSWIRE) -- CSW Industrials, Inc. (NASDAQ:CSWI), a diversified industrial growth company with well-established, scalable platforms and domain expertise across two segments: Industrial Products and Specialty Chemicals, today reported results for the fiscal third quarter ended December 31, 2018.
Net revenue during the fiscal third quarter of 2019 increased 12.3% to $77.5 million, compared to $69.0 million in the prior year period. Higher revenue was driven by increased sales in both the Industrial Products and Specialty Chemicals segments primarily in the HVAC, architecturally-specified building products and general industrial end markets.
GAAP operating income from continuing operations increased 19.0% to $9.4 million, compared to $7.9 million in the prior year period. The increase was driven by increased sales volumes.
Net income from continuing operations in the fiscal third quarter of 2019 was $6.0 million, or $0.39 per diluted share, compared to $2.6 million, or $0.17 per diluted share, in the prior year period. Adjusted to apply a normalized tax rate, adjusted net income from continuing operations in the fiscal third quarter of 2019 was $7.0 million, or $0.46 per diluted share, compared to $5.1 million, or $0.32 per diluted share, in the prior year period.
Joseph B. Armes, CSW Industrials’ Chief Executive Officer, commented, “We are pleased to report excellent third quarter results highlighted by double-digit organic revenue growth, which helped to bolster margins and generate 37% growth in adjusted net income. We continue to outpace the growth of the end markets we serve, which we attribute to our talented global workforce, customer focus, industry leading brands and quality products.”
Armes continued, “We continue to steward well the capital entrusted to us by directing cash to the opportunities providing the greatest risk-adjusted return. Underscoring this commitment, we returned $9.9 million to shareholders through share repurchases in the third fiscal quarter 2019 bringing the year-to-date total to $40.7 million.”
Third Quarter Results of Operations
Consolidated revenue from continuing operations increased 12.3% to $77.5 million, compared to $69.0 million in the prior year period.
Industrial Products segment revenue increased 15.3% to $43.7 million, compared to $37.9 million in the prior year period. Higher revenue was mainly the result of increased sales volume in HVAC and architecturally-specified building products end markets. GAAP segment operating income increased 11.0% to $8.1 million, compared to $7.3 million in the prior year period.
Specialty Chemicals segment revenue increased 8.7% to $33.8 million, compared to $31.1 million in the prior year period. Increased sales were driven by higher volumes in the general industrial and architecturally-specified building products end markets. GAAP segment operating income increased 17.9% to $4.6 million, compared to $3.9 million in the prior year period.
Consolidated gross profit increased 13.2% to $34.2 million, compared to $30.2 million in the prior year period. Gross margin as a percentage of sales increased to 44.2%, compared to 43.8% in the prior year period driven by sales leverage across operating segments.
Consolidated operating expenses in the current quarter were $24.8 million, or 32.0% of sales, and declined 30 basis points over the prior year level of $22.3 million, or 32.3% of sales. The increase in operating expenses was primarily driven by increased performance-based compensation as a result of stronger operating results and increased spending in the Industrial Products related to an ERP system upgrade of $0.4 million.
Reported net earnings from continuing operations increased to $6.0 million, or $0.39 per diluted share, compared to $2.6 million, or $0.17 per diluted share in the prior year period. Adjusted to apply a normalized tax rate, adjusted net earnings from continuing operations in the fiscal third quarter of 2019 increased 37.3% to $7.0 million, or $0.46 per diluted share, compared to adjusted income from continuing operations of $5.1 million, or $0.32 per diluted share, in the prior year period.
Conference Call Information
The company will host a conference call today at 10:00 a.m. ET to discuss the results, followed by a question and answer session for the investment community. A live webcast of the call can be accessed at ir.cswindustrials.com. To access the call, participants may dial toll-free at 1-877-407-0784 or 1-201-689-8560 (international) and request to join the CSW Industrials earnings call.
To listen to a telephonic replay of the conference call, dial toll-free 1-844-512-2921 or 1-412-317-6671 (international) and enter confirmation code 13686796. The telephonic replay will be available beginning at 1:00 p.m. ET on Tuesday, February 5, 2019, and will last through 11:59 p.m. ET on Tuesday, February 19, 2019. The call will also be available for replay via the webcast link on CSW Industrials’ Investor Relations website.
Safe Harbor Statement
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. Words or phrases such as "may," "should," "expects," "could," "intends," "plans," "anticipates," "estimates," "believes," "forecasts," "predicts" or other similar expressions are intended to identify forward-looking statements, which include, without limitation, earnings forecasts, effective tax rate, statements relating to our business strategy and statements of expectations, beliefs, future plans and strategies and anticipated developments concerning our industry, business, operations and financial performance and condition.
The forward-looking statements included in this press release are based on our current expectations, projections, estimates and assumptions. These statements are only predictions, not guarantees. Such forward-looking statements are subject to numerous risks and uncertainties that are difficult to predict. These risks and uncertainties may cause actual results to differ materially from what is forecast in such forward-looking statements, and include, without limitation, the risk factors described from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.
All forward-looking statements included in this press release are based on information currently available to us, and we assume no obligation to update any forward-looking statement except as may be required by law.
Non-GAAP Financial Measures
This press release includes an analysis of adjusted earnings per share, adjusted net income, and adjusted operating income, which are non-GAAP financial measures of performance. For a reconciliation of these measures to the most directly comparable GAAP measures and for a discussion of why we consider these non-GAAP measures useful, see the “Reconciliation of Non-GAAP Measures” section of this release.
About CSW Industrials
CSWI is a diversified industrial growth company with well-established, scalable platforms and domain expertise across two segments: Industrial Products and Specialty Chemicals. CSWI's broad portfolio of leading products provides performance optimizing solutions to its customers. CSWI's products include mechanical products for heating, ventilation and air conditioning ("HVAC") and refrigeration applications, sealants and high performance specialty lubricants. Markets that CSWI serves include: HVAC, industrial, rail, plumbing, architecturally-specified building products, energy, mining and general industrial markets.
|Consolidated Income Statements|
|Three Months Ended |
|Nine Months Ended |
|(Amounts in thousands, except per share amounts)||2018||2017||2018||2017|
|Cost of revenues||(43,260||)||(38,826||)||(140,153||)||(131,013||)|
|Selling, general and administrative expenses||(24,807||)||(22,270||)||(74,156||)||(72,581||)|
|Interest expense, net||(289||)||(540||)||(1,094||)||(1,842||)|
|Other income, net||336||375||1,157||994|
|Income before income taxes||9,468||7,775||44,432||38,315|
|Provision for income taxes||(3,471||)||(5,140||)||(12,005||)||(16,243||)|
|Income from continuing operations||5,997||2,635||32,427||22,072|
|Income (loss) from discontinued operations, net of tax||(1,016||)||(36,672||)||(616||)||(40,293||)|
|Basic earnings (loss) earnings per common share:|
|Diluted earnings (loss) earnings per common share:|
|Consolidated Balance Sheets|
|(Amounts in thousands, except per share amounts)||December 31, 2018||March 31, 2018|
|Cash and cash equivalents||$||14,624||$||11,706|
|Accounts receivable, net of allowance for doubtful accounts of $701 and $1,015, respectively||50,277||63,383|
|Prepaid expenses and other current assets||9,323||7,077|
|Current assets, discontinued operations||21||2,427|
|Total current assets||124,689||127,567|
|Property, plant and equipment, net of accumulated depreciation of $64,911 and $61,967, respectively||52,720||54,473|
|Intangible assets, net||47,376||53,054|
|LIABILITIES AND EQUITY|
|Accrued and other current liabilities||29,138||23,501|
|Current portion of long-term debt||561||561|
|Current liabilities, discontinued operations||168||3,966|
|Total current liabilities||44,381||44,854|
|Retirement benefits payable||1,789||2,017|
|Other long-term liabilities||5,484||4,721|
|Noncurrent liabilities, discontinued operations||964||-|
|Common shares, $0.01 par value||158||158|
|Shares authorized – 50,000|
|Shares issued – 16,000 and 15,957, respectively|
|Additional paid-in capital||45,576||42,684|
|Treasury shares, at cost (866 and 80 shares, respectively)||(45,007||)||(3,252||)|
|Accumulated other comprehensive loss||(10,438||)||(7,475||)|
|Total liabilities and equity||$||317,484||$||340,816|
|Consolidated Statements of Cash Flow|
|Nine Months Ended December 31,|
|(Amounts in thousands)||2018||2017|
|Cash flows from operating activities:|
|Less: loss from discontinued operations||(616||)||(40,293||)|
|Income from continuing operations||32,427||22,072|
|Adjustments to reconcile net income to net cash provided by operating activities:|
|Amortization of intangible and other assets||4,799||5,450|
|Provision for inventory reserves||822||220|
|Provision for doubtful accounts||126||(6||)|
|Share-based and other executive compensation||2,893||3,329|
|Net gain on disposals of property, plant and equipment||(2,854||)||(89||)|
|Net pension benefit||(296||)||(974||)|
|Net deferred taxes||10,225||(430||)|
|Changes in operating assets and liabilities:|
|Accounts receivable, net||12,450||8,673|
|Prepaid expenses and other current assets||(2,263||)||375|
|Accounts payable and other current liabilities||1,755||10,343|
|Retirement benefits payable and other liabilities||(19||)||(6,357||)|
|Net cash provided by operating activities, continuing operations||58,281||47,050|
|Net cash used in operating activities, discontinued operations||(8,401||)||(8,291||)|
|Net cash provided by operating activities||49,880||38,759|
|Cash flows from investing activities:|
|Proceeds from sale of assets held for investment||2,102||546|
|Proceeds from sale of assets||3,291||22|
|Net change in bank time deposits||-||1,840|
|Net cash provided by (used in) investing activities, continuing operations||627||(1,855||)|
|Net cash provided by (used in) investing activities, discontinued operations||7,356||(825||)|
|Net cash provided by (used in) investing activities||7,983||(2,680||)|
|Cash flows from financing activities:|
|Borrowings on lines of credit||8,000||-|
|Repayments of lines of credit||(20,421||)||(33,046||)|
|Payments of deferred loan costs||-||(422||)|
|Purchase of treasury shares||(41,755||)||(997||)|
|Proceeds from stock option activity||-||328|
|Net cash used in financing activities||(54,176||)||(34,137||)|
|Effect of exchange rate changes on cash and equivalents||(769||)||1,454|
|Net change in cash and cash equivalents||2,918||3,396|
|Cash and cash equivalents, beginning of period||11,706||23,146|
|Cash and cash equivalents, end of period||$||14,624||$||26,542|
Reconciliation of Non-GAAP Measures
|Reconciliation of Operating Income to Adjusted Operating Income---Continuing Operations|
|(in thousands)||Quarter Ended December 31,||Nine Months Ended December 31,|
|GAAP Operating Income- Continuing Operations||$||9,421||$||7,940||$||44,369||$||39,163|
|Restructuring & realignment||-||-||-||1,243|
|Gain on sale of property & other||-||-||(1,839||)||-|
|M&A transaction costs||-||-||110|
|Adjusted Operating Income--Continuing Operations||$||9,421||$||7,940||$||42,530||$||40,516|
|Reconciliation of Net Income to Adjusted Net Income---Continuing Operations|
|(in thousands, except share data)||Quarter Ended December 31,||Nine Months Ended December 31,|
|GAAP Net Income---Continuing Operations||$||5,997||$||2,635||$||32,427||$||22,072|
|Adjusting items, net of tax:|
|Restructuring & realignment||-||-||-||808|
|Gain on sale of property & other||-||-||(1,361||)||-|
|M&A transaction costs||-||-||-||71|
|Discrete Tax Provisions & Other||1,009||2,419||452||2,635|
|Adjusted Net Income---Continuing Operations||$||7,006||$||5,054||$||31,518||$||25,586|
|GAAP Diluted income per common share, Continuing operations||$||0.39||$||0.17||$||2.07||$||1.41|
|Adjusting items, per diluted common share:|
|Restructuring & realignment||-||-||-||0.06|
|Gain on sale of property & other||-||-||(0.08||)||-|
|M&A transaction costs||-||-||0.01|
|Discrete Tax Provisions & Other||0.07||0.15||0.03||0.16|
|Adjusted earnings per diluted common share||$||0.46||$||0.32||$||2.02||$||1.64|
|Weighted-average shares outstanding (in thousands)|
|Reconciliation of Segment Operating Income to Adjusted Segment Operating Income|
|(in thousands, except percentages)||For the Three Months Ended December 31, 2018||For the Three Months Ended December 31, 2017|
|Industrial Products||Specialty Chemicals||Corporate and Other||Consolidated |
|Industrial Products||Specialty Chemicals||Corporate and Other||Consolidated |
|No Adjusting items:|
|Adjusted Operating Income||$||8,059||$||4,574||$||(3,212||)||$||9,421||$||7,323||$||3,890||$||(3,273||)||$||7,940|
|% of revenue||18.5||%||13.5||%||12.2||%||19.3||%||12.5||%||11.5||%|
|(in thousands, except percentages)||Year to date December 31, 2018||Year to date December 31, 2017|
|Industrial Products||Specialty Chemicals||Corporate |
|Industrial Products||Specialty Chemicals||Corporate |
|Restructuring & realignment||-||-||-||-||367||876||-||1,243|
|Gain on sale of property & other||(253||)||(1,586||)||-||(1,839||)||-||-||-||-|
|M&A transaction costs||-||-||-||-||110||-||-||110|
|Adjusted Operating Income||$||35,911||$||15,619||$||(9,000||)||$||42,530||$||33,762||$||15,546||$||(8,792||)||$||40,516|
|% of revenue||23.6||%||14.7||%||16.4||%||24.2||%||15.1||%||16.7||%|
We use adjusted earnings per share, adjusted net income and adjusted operating income, together with financial measures prepared in accordance with GAAP, such as revenue, income from operations, operating expense, operating income and net income, to assess our historical and prospective operating performance and to enhance our understanding of our core operating performance. We also believe these measures are useful for investors to assess the operating performance of our business without the effect of non-operating items.
Michael Callahan, ICR